gallium nitrate has been researched along with Carcinoma, Epidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blessing, JA; Hanjani, P; Homesley, HD; Malfetano, JH | 1 |
| Bergeron, R; Honeysett, JM; Taetle, R | 1 |
1 trial(s) available for gallium nitrate and Carcinoma, Epidermoid
| Article | Year |
|---|---|
A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Gallium; Humans; Middle Aged; Uterine Cervical Neoplasms | 1991 |
1 other study(ies) available for gallium nitrate and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Combination iron depletion therapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chelating Agents; Drug Screening Assays, Antitumor; Female; Gallium; Granulocytes; Hematopoietic Stem Cells; Humans; Immunoglobulin A; Iron Deficiencies; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Macrophages; Ovarian Neoplasms; Oxazoles; Receptors, Transferrin; Tumor Cells, Cultured | 1989 |